EzHomeo editorial policy
How Omnoryx Technologies publishes product documentation and educational material on ezhomeo.com.
Ownership and purpose
EzHomeo content is produced by the EzHomeo editorial and product teams at Omnoryx Technologies Pvt Ltd. The company sells EzHomeo, so product pages and category guides have a commercial interest. We label that relationship instead of presenting vendor-authored material as independent research.
Product claims
Product claims are reviewed by the accountable product owner against the current product, internal operating figures, approved customer evidence and governing policies before publication. Corrections are made when a feature, figure or commercial term changes; approved first-party figures are identified as EzHomeo information.
Sources and review
Educational articles prefer primary or authoritative sources and link them where the relevant claim appears. Product behavior is checked against the implemented workflow and current policies. EzHomeo does not currently claim external clinical review of its editorial content. Nothing on this site replaces medical training, professional standards or independent clinical judgment.
AI-assisted drafting
Automated tools may assist research, drafting, formatting or quality checks. A human product owner remains accountable for publication. Material changes are checked for source support, product accuracy, internal-link integrity and consistency with the privacy policy and terms.
Dates, updates and corrections
An article’s published and reviewed dates appear on the page and in its structured data. Dates change only when the content receives a material review. To report an error, email contact@ezhomeo.com with the page URL, disputed wording and supporting evidence. Confirmed material errors are corrected in the page and its machine-readable summaries.
Privacy and clinical boundaries
The Privacy Policy and Terms and Conditions govern their respective subjects. Marketing summaries must not make broader promises. EzHomeo is decision-support software; the practitioner remains responsible for diagnosis, prescription, dosage, treatment and follow-up.